Immunic Inc (NASDAQ:IMUX)’s Trend Unknown, Especially After Increased Shorts

The stock of Immunic Inc (NASDAQ:IMUX) registered an increase of 8.15% in short interest. IMUX’s total short interest was 140,700 shares in September as published by FINRA. Its up 8.15% from 130,100 shares, reported previously. With 219,300 shares average volume, it will take short sellers 1 days to cover their IMUX’s short positions. The short interest to Immunic Inc’s float is 0.34%.

The stock increased 4.10% or $0.57 during the last trading session, reaching $14.48. About 32,250 shares traded. Immunic, Inc. (NASDAQ:IMUX) has declined 95.65% since September 13, 2018 and is downtrending. It has underperformed by 95.65% the S&P500.

Immunic, Inc., a clinical-stage biopharmaceutical firm developing a pipeline of selective oral immunology therapies for treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company has market cap of $146.15 million. The Company’s lead development program is IMU-838, a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH, which is in phase II clinical development for treatment of ulcerative colitis and relapsing-remitting multiple sclerosis. It currently has negative earnings. The firm is also developing IMU-935, an inverse agonist of RORyt; and IMU-856 for the restoration of the intestinal barrier function.

More notable recent Immunic, Inc. (NASDAQ:IMUX) news were published by: Benzinga.com which released: “25 Stocks Moving in Friday’s Pre-Market Session – Benzinga” on September 06, 2019, also Benzinga.com with their article: “46 Stocks Moving In Friday’s Mid-Day Session – Benzinga” published on September 06, 2019, Finance.Yahoo.com published: “Could Immunic, Inc.’s (NASDAQ:IMUX) Investor Composition Influence The Stock Price? – Yahoo Finance” on July 19, 2019. More interesting news about Immunic, Inc. (NASDAQ:IMUX) were released by: Prnewswire.com and their article: “Immunic, Inc. to Participate in Scientific and Investor Conferences in September – PRNewswire” published on September 03, 2019 as well as Nasdaq.com‘s news article titled: “Health Care Sector Update for 09/06/2019: MNK,IMUX,CRON,CRON.TO,VIVE – Nasdaq” with publication date: September 06, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.